$ASRT News

Lake Street Maintains Hold on Assertio Hldgs, Raises Price Target to $23.5

Assertio Agrees To Be Acquired By Zydus Worldwide For $23.50 Per Share In Cash

HC Wainwright & Co. Maintains Neutral on Assertio Hldgs, Raises Price Target to $21.8

Assertio, Garda Therapeutics Enter Into Amended And Restated Agreement And Plan Of Merger; Garda Increases Offer To Acquire All Outstanding Shares Of Assertio To $21.80 Per Share In Cash With No Contingent Value Right

Lake Street Downgrades Assertio Hldgs to Hold, Lowers Price Target to $18

HC Wainwright & Co. Downgrades Assertio Hldgs to Neutral, Lowers Price Target to $18

Cosette Pharmaceuticals Acquires The U.S. Sales And Distribution Rights For A Portfolio Of 7 Branded Products From Assertio Holdings

Assertio Holdings Agrees To Sell All Non-Rolvedon Assets To Cosette Pharmaceuticals As Part Of Merger Agreement With Garda Therapeutics

Assertio Holdings Agrees To Sell All Non-Rolvedon Assets To Cosette Pharmaceuticals As Part Of Merger Agreement With Garda Therapeutics

Assertio Holdings Agrees To Be Acquired By Garda Therapeutics For Total Consideration Of $125.1M

Assertio: Why I'm Selling The Rally (Rating Downgrade)

Assertio Holdings, Inc. (ASRT) Q4 2025 Earnings Call Transcript

Assertio Holdings Sees FY2026 Sales $110.000M-$125.000M vs $111.960M Est

Assertio Holdings Q4 Adj. EPS $(1.06) Beats $(2.71) Estimate, Sales $13.542M Miss $16.626M Estimate

Assertio Holdings Regains Compliance With All Applicable Nasdaq Listing Requirements

Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial

Assertio Data From Clinical Study Of Rolvedon Injection Demonstrates Effective Neutrophil Recovery

HC Wainwright & Co. Maintains Buy on Assertio Holdings, Raises Price Target to $35

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

Trading Halt: Halted at 4:50:00 p.m. ET - Trading Halt: Halt News Pending